Fintel reports that on September 27, 2024, Leerink Partners downgraded their outlook for Agios Pharmaceuticals (NasdaqGS:AGIO ...

On Friday, Geron Corp (GERN) stock saw a modest uptick, ending the day at $4.57 which represents a slight increase of $0.14 or 3.16% from the prior close of $4.43. The stock opened at $4.47 and ...

Agios Pharmaceuticals (AGIO) stock was downgraded at Leerink Partners on Pfizer's (PFE) recent decision to withdraw sickle ...

Leerink Partners analyst Faisal Khurshid said that he likes the “risk/reward” profile of Immunic’s CALLIPER trial readout, ...

On Friday, Ardelyx Inc (ARDX) stock saw a modest uptick, ending the day at $6.65 which represents a slight increase of $0.29 or 4.56% from the prior close of $6.36. The stock opened at $6.43 and ...

In a report released on September 25, Marc Goodman from Leerink Partners maintained a Hold rating on Alkermes (ALKS – Research Report).

Pfizer’s sudden market withdrawal of sickle cell therapy Oxbryta, which some analysts predicted would reach $750 million in ...

Leerink Partners analyst Mani Foroohar has maintained their bullish stance on ENGN stock, giving a Buy rating on September 27. Mani Foroohar ...

Capstan Therapeutics to participate in Goldman Sachs Cell Therapy Day 2024 and Leerink Partners Biopharma Private Company Connect.

Exact Sciences (EXAS) stock and Quanterix (QTRX) stock dropped after CMS issued worse than expected preliminary payment rates ...

Guggenheim Securities, LLC served as financial advisor to eClinical Solutions. Morse, Barnes-Brown & Pendleton, and Choate Hall & Stewart LLP served as legal counsel to eClinical Solutions. Leerink ...

Novo Nordisk’s American depositary receipts tumbled almost 6% Friday after the drugmaker reported mixed results from a study of an experimental weight-loss pill. The pill, monlunabant, helped people ...